CMG vs PTGX · P/E 50, rev $3.35B vs rev $269.8M
Chipotle Mexican Grill Inc (CMG) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
Chipotle Mexican Grill Inc (CMG) is a restaurants company listed on US.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported CMG revenue for 2026-06-30 was $3.35B. Net income was $403.5M. Revenue was up 8.4% from 2026-03-31 to 2026-06-30. CMG currently screens at market cap $76.00B and trailing P/E 50.0.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
CMG currently screens at market cap $76.00B and trailing P/E 50.0. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the CMG and PTGX stock pages for the full models.
Not investment advice.